PROVID, DUKE COLLABORATE ON HUNTINGTON'S TREATMENT
Provid Pharmaceuticals and the Duke University Medical Center Division of Neurology have entered into a research collaboration to identify compounds that may aid in the treatment of Huntington's disease. Research will focus on developing bioavailable molecules to inhibit cellular activity associated with the disease's progressive neurological and cognitive deterioration.